Syohei Koyama

25PUBLICATIONS
176CO-AUTHORS
Predictive and prognostic markersMolecular targetsAutoimmunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 29, 2026
Pharmacokinetic variability with pembrolizumab dosage switching and its impact on immune-related adverse events in patients with non-small cell lung cancer.

|Apr 27, 2026
Lenvatinib Combined with PD-1 Blockade Therapy Benefits Gastric Cancers through Immunosuppressive Macrophage Modulation.

|Apr 15, 2026
On-demand GLUT3 expression augments CAR T cell metabolic fitness and antitumor efficacy in preclinical models of glioblastoma.

|Feb 04, 2026
Concurrent Pituitary and Thyroid Immune-Related Adverse Events after Immune Checkpoint Inhibitors Associated with HLA-DR15-Related Haplotypes.

Tomoko Kobayashi, Shintaro Iwama, Eri Sugiyama

|Jan 30, 2026
Impact of Sequential Ramucirumab Plus Docetaxel After PD-1 Inhibitors on Anti-PD-1 Antibody-Bound T-Cell Dynamics and Clinical Outcomes.

Kinnosuke Matsumoto, Yujiro Naito, Takayuki Shiroyama

|Nov 20, 2025
Spatial Multiomic Analyses Reveal Carcinogenic Pathways in End-Stage Renal Disease.

Jun Takahashi, Yosuke Tanaka, Yusuke Sato

Pageof 5

Frequent Collaborators

13 joint publications

Hiroyoshi Nishikawa

6 joint publications

Kohei Shitara

4 joint publications

Genichiro Ishii

4 joint publications

Akihito Kawazoe